New Blood-Based injection could beat PRP for knee pain
NCT ID NCT06932614
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a new, concentrated version of a patient's own blood platelets (called self-repair factor) works better than standard platelet-rich plasma (PRP) injections for knee osteoarthritis. 90 adults with mild to moderate knee arthritis will receive either the new factor, PRP, or a placebo. The goal is to see which treatment best reduces pain and improves knee function over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lyophilized self growth factor (a concentrated form of the patient's own blood platelets)
What this could lead to
If it works, this could offer a more effective injection treatment for knee osteoarthritis pain and stiffness, potentially better than current PRP therapy.
What could go wrong
This is a small, early-stage trial with only 90 people. The new treatment may not prove better than PRP or placebo, and individual results vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 325, Sec. 2, Chenggong Rd., Neihu Dist.
RECRUITINGTaipei, 114, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••